Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
Politicians who traded ARGX
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 2
- Filings
- 2
- Members
- 2
- Buys / sells
- 1 / 1
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Alan Armstrong Senate · OK | 1 | 1 / 0 | $8.00K | Mar 30, 2026 | Jul 21, 2026 |
| Daniel S. Goldman House · NY | 1 | 0 / 1 | $8.00K | Jul 10, 2023 | Aug 13, 2023 |
Trades
Reported trades in Argenx SE, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Alan Armstrong Senate · OK | ARGXargenx SE - American Depositary Shares | Buy | Self | Mar 30, 2026 | Jul 21, 2026 | 113 daysLate | $1K-$15K | Filing |
| Daniel S. Goldman House · NY | ARGXargenx SE - American Depositary Shares | Sell | Self | Jul 10, 2023 | Aug 13, 2023 | 34 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.